Biblio

Author Title [ Type

] Year

Filters: Author is Vettenranta, Kim [Clear All Filters]

Journal Article

Levinsen M, Harila-Saari A, Grell K, Jonsson OGisli, Taskinen M, Abrahamsson J, Vettenranta K, Åsberg A, Risteli J, Heldrup J, et al. Efficacy and Toxicity of Intrathecal Liposomal Cytarabine in First-line Therapy of Childhood Acute Lymphoblastic Leukemia. J Pediatr Hematol Oncol. 2016.

Niinimäki R, Hansen LMølgaard, Niinimäki T, Olsen JH, Pokka T, Sankila R, Vettenranta K, Hasle H, Harila-Saari A. Incidence of Severe Osteonecrosis Requiring Total Joint Arthroplasty in Children and Young Adults Treated for Leukemia or Lymphoma: A Nationwide, Register-Based Study in Finland and Denmark. J Adolesc Young Adult Oncol. 2013;2(4):138-144.

Willasch AManfred, Peters C, Sedlacek P, Dalle J-H, Kitra-Roussou V, Yeşilipek A, Wachowiak J, Lankester A, Prete A, Hamidieh AAli, et al. Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?-A multicenter EBMT-PDWP study. Bone Marrow Transplant. 2020.

Rahiala J, Koskenvuo M, Sadeghi M, Waris M, Vuorinen T, Lappalainen M, Saarinen-Pihkala U, Allander T, Söderlund-Venermo M, Hedman K, et al. Polyomaviruses BK, JC, KI, WU, MC, and TS in children with allogeneic hematopoietic stem cell transplantation. Pediatr Transplant. 2016;20(3):424-431.

Teppo E, Penttinen J, Myöhänen O, Vettenranta K, Lohi O. Single-centre study reports a 84% five-year overall survival rate for paediatric solid tumors. Acta Paediatr. 2016.